Search

everythinglearnresearchcommunity

for

Search:↓

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

BST2 protein and certain T cells increase in early alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Scientists created keratinocyte cell lines from human hair that can differentiate similarly to normal skin cells, offering a new way to study skin biology and diseases.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Hair loss treatment caused more hair loss in a man.

Restoring hair follicle immune privilege may help treat alopecia areata.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.